You may not know the company, but it’s likely you’re familiar with the problem it’s solving for.
“Etira is tackling tumor heterogeneity,” said Etira Life CEO Russell Hayward.
Tumor heterogeneity refers to the complex mix of different cancer cell genotypes, phenotypes, or mutations that make up an individual tumor. ...